Infective endocarditis is a disease characterized by endocardial involvement, where vegetations infected by microorganisms form on the valves, cardiac chambers, and endothelium of large blood vessels. It is potentially fatal, with an incidence of 3 to 7 cases per 100,000 people per year. Diagnosis is made according to the modified Duke criteria, which include two major and five minor criteria. The most common infectious agents are Streptococcus viridans, Streptococcus bovis, HACEK group, and Staphylococcus aureus. Streptococcus gallolycticus is a rare causative agent in infective endocarditis, occurring in 18% of cases. Colorectal cancer is almost pathognomonic, present in up to 71% of cases, and of these, 5% are associated with prosthetic valves. For colorectal cancer, blood cultures, echocardiograms, and colonoscopies are necessary. According to the evolution time of the biological prosthetic valve, it is considered early when it presents clinical symptoms within the first year and late when it presents 1 year after the replacement.

Background: Diabetes Mellitus type 2 (T2DM) is an epidemic metabolic condition that is typified by persistent hyperglycemia. Although the gold standard in the evaluation of long-term glycemic control is glycated hemoglobin (HbA1c), the polyol 1.5-anhydroglucitol (1.5-AG), a naturally occurring polyol, is reabsorbed in the renal tubules and is competitively inhibited by glucose, thus it may represent early glucose fluctuations. Change in 1.5-AG is a reflection of the variation in blood glucose over one to two weeks. Objective: The objective of the study was to establish the relationship between serum 1,5-AG and glycemic control variables (HbA1c, FBS) in T2DM patients. Materials and Methods: The study was a cases control study where 60 healthy controls were used, and 60 T2DM patients were used. 1.5-AG has been demonstrated to indicate change in blood glucose over a period of one to two weeks. An ELISA kit was used to measure serum 1, 5-AG. Fasting glucose, insulin (with a Maglumi device), insulin resistance index (HOMA-IR), renal function test (B.Urea and S.Cr) and GH-900Plus HbA1c Analyzer. Results: Serum 1.5-AG was also found to be lower in the T2DM patients than the control group (9.31 ± 4.73 mg/L vs. 22.39 + 8.20 mg/L; p<0.001). There was a considerable negative correlation between (1.5-AG and FBS, HbA 1c and HOMA-IR). The receiver operating characteristic (ROC) curve analysis indicated the diagnostic accuracy of (1.5-AG on T2DM (AUC = 0.94)) was high and the best cutoff value of 11.95mg/L offered 85.0% sensitivity and 98.3% specificity. Conclusion: It is possible to consider that 1.5-AG is a good marker to study levels in people with type 2 diabetes during the period of one to two weeks. More research will be required to ascertain the use of these chemicals in diagnosis. The blood glucose variations in the patients with T2DM. Specifically the people who are below 180mg/dl and those above 180mg/dl of blood sugar.

Background: Chronic inflammation and dyslipidemia are part of type 2 diabetes mellitus (T2DM) associated cardiovascular complications. Interleukin-6 (IL-6) and interleukin-17 (IL-17) are pro-inflammatory cytokines associated with metabolic disturbances. Objectives: To evaluate the levels of IL-6 and IL-17 in serum of T2DM patients, and to explore their association with lipid profile parameters. Methods: A case-control study with 100 individuals was carried out including T2DM patients (n=50) and healthy group as a control group (n=50). Demographic information was collected such as age, sex and body mass index (BMI). The concentrations of IL-6 and IL-17 were detected by enzyme-linked immunosorbent assay (ELISA). Serum lipid profile, including total cholesterol (TC), triglycerides (TG), low density lipoprotein-cholesterol (LDL-C) and high-density lipoprotein-cholesterol (HDL-C) was evaluated. The data was analyzed using SPSS version 26.0 control-group software. Results: The T2DM patients had significantly higher level of IL-6 (48.3 ± 12.4 pg/mL vs. 18.2±5.6 pg/mL, p<0.001) and of IL-17 (35.7±9.8 pg/mL vs 12.4±4.2 pg/ml, p<0.l)) than control subjects. T2DM patients had a higher incidence of lipid abnormalities, such as increased TC, TG and LDL-C levels, and decreased HDL-C level. IL-6 was positively correlated with TG (r=0.64, p<0.001), TC (r=0.52, p<0.001), and LDL-C (r=0.48, p<0.001). IL-17 significantly correlated with TG (r=0.58, p<0.001) and LDL-C (r=0.44, p<0.01). Both cytokines were inversely associated with HDL-C. Conclusion: Increased levels of IL-6 and IL-17 in T2DM patients are significantly associated with dyslipidemia, supporting their potential value as inflammatory biomarkers for cardiovascular risk analysis in diabetic population.

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive disorder of fibrosing interstitial lung disease with variable courses of the disease. Emerging evidence suggests a correlation between immunometabolic remodeling of myeloid cells in the blood and fibrosis severity and progression. Succinate is capable of signaling metabolite, and HIF-1 and 1 alpha unifies metabolic and inflammatory stress response, providing an inviting axis which is relevant to fibrosis biology. Objective: To assess the discriminatory ability of serum succinate and PBMC HIF-1 alpha (and a composite score with succinate and HIF alpha Information [Successful discrimination]), of fibrosis severity and progression in IPF compared to controls. Methods: A case Butler clinical biomarker research capable of 100 medical sombre stages in the pattern of 50 are observed with IPF and the other 50 to serve as a control person. Serum succinate and cytokines (IL-1 beta, TNF alpha and TGF beta 1) were measured by enzyme immunoassay (ELIZA). HIF-1a was analyzed in lysates of the PBMCs (normalized on total protein). The severity of fibrosis was measured by HRCT fibrosis extent score, FVC% predicted, and DLCO% predicted. Group comparisons were performed using t-tests or a Mann-Whitney U tests as appropriate and categorical variables were performed using chi-square tests. Associations with severity were evaluated by using Spearman correlations and multivariable linear regression with age, sex, BMI and smoking. Progression risk was assessed in IPF by stable vs progressive classification, ROC/AUC statistical analyses and adjusted logistic regression. Results: Baseline characteristics were similar between groups (age, BMI, sex and ever-smoking; all p> 0.05). IPF had significantly increased serum Succinate (median, 3.14 [3.00-3.49] vs 2.24 [2.06-2.35] umol/l; p < 0.001) and PBMC HIF-1a (187.6 (+-21.6) vs 129.3 (+-27.2) pg/mg protein; P < 0.001). IL-1 beta and TNF alpha were up in IPF (both p<0.001) and TGF beta 1 slightly (p=0.013). Succinate was associated with HRCT score (rho=0.734, p<0.001), FVC% (rho=-0.480, p<0.001) and DLCO% (rho=-0.612, p<0.001) in IPF. A positive correlation was found between HIF-1a and HRCT (rho=0.360, p=0.010) and DLCO% (rho=-0.343, p=0.015). In adjusted models, succinate was independently associated with HRCT (bet (adjusted) = 13.991 per 1umol/L; p<0.001) and DLCO% (bet = -22.633; p<0.001), whereas HIF-1alpha was independently associated with HRCT (beta = 0.839 per 10 pg/mg; p=0.011) and DLCO% (beta = -1.207; p=0.013). Progression analysis revealed an increase in PBMC HIF-1a (p=0.003) and increase in axis score (p=0.008) during progressive disease. ROC analyses revealed the AUC value of succinate (0.608), HIF-1 alpha (0.794), and the axis score (0.755). Axis score was found to be an independent predictor of progression (OR = 3.33 per 1 SD; p= 0.012). Conclusion: The modelled results confirm the hypothesis that succinate and PBMC HIF-1 alpha are immunometabolic phenotype indicators related to the severity of IPF and that PBMC HIF-1 alpha and Succinate-HIF axis score are stronger signal for progression risk. Validation in external, real-world cohorts, assay harmonization and longitudinal replication are needed before the clinical translocation.

Women in low-resource communities are women who live in environments with limited access to economic, social, educational, and healthcare resources. Their lives are shaped by poverty, inequality, and structural barriers that affect their well-being and opportunities. The psychosocial impacts of infertility are often more intense and complex for women in low-resource communities because infertility intersects with poverty, gender inequality, and limited access to health and social support systems. The psychosocial impacts of infertility and women in low-resource communities are deeply intertwined. Infertility is not only a medical condition but a social and psychological crisis that can affect women’s identity, mental health, safety, and economic survival. Infertility among women in low-resource communities is not caused by women themselves, but is often the result of social, economic, and healthcare-related factors that increase health risks. Infertility has serious psychosocial impacts on women in low-resource communities because motherhood is often closely linked to a woman’s social status, identity, and security. This study is aim to evaluate the Psychosocial Impacts of Infertility Among Women in Low-Resources Communities in South-South, Nigeria. This was a cross-sectional study involving 250 women with age between 18 to 47 years. A well-structured questionnaire was administered to participants. The study lasted for a period of 3 months. Statistical analysis was done using SPSS version 25.0 and p < 0.05 was significant. The results revealed that 68% of the participants were married, 60% has married for more than 5 years, 60% residence in rural areas, 60% had secondary level of education, 80% were of low class, 80% have not sought medical help for infertility, 70% sought traditional healer, 68% had stress, 76% are anxious or worried, 72% are sad, 80% are pressured, 80% had relationship affected, 80% had family relationship affected, majority had economic impacts.

Dermatophytosis is a category of superficial fungi infection caused by the keratinophilic fungi, like Trichophyton rubrum, which attacks the conventional antifungal drugs less often. This article compared the antifungal activity of aqueous and alcoholic extracts of Senna alata, Ficus carica and Ricinus communis against Trichophyton rubrum isolates obtained on human infections in Babylon Province in Iraq compared with itraconazole. The strongest antifungal activity was availed by Senna alata, aqueous extract and the alcoholic extract of Senna alata, in comparison with itraconazole. Statistical work was done with (One-way ANOVA) that revealed that there were significant differences between extracts (p < 0.05). These results suggest the possibility of Senna alata extract as a natural antifungal agent considering that it is safe, accessible, and can be used as an addition to managing dermatophytosis.

Background: Type 2 diabetes mellitus (T2DM) is a metabolic disease that is lifelong and is associated with hyperglycemia, oxidative stress, and other dysfunctions of the organs. The antioxidant effect and bioavailability of selenium nanoparticles have been of interest, particularly whereby the nanoparticles have been stabilized using biocompatible polymers such as chitosan. Aim: The study in question was aimed at comparing the effects of metformin and chitosan-selenium nanoparticles (Cs-Se NPs) on biochemical and histopathological levels in an experimental model of type 2 diabetes in rats induced artificially. Materials and Methods: One hundred albino adult rats were separated into 6 groups i.e. control negative, control positive (alloxan induced diabetes), 1.5, 3 and 5mg/kg SCNP treated diabetic and a 500mg/kg metformin treated diabetic group. Alloxan was used to induce diabetes. The UV-Vis spectroscopy, XRD, FTIR, SEM, and AFM were used to characterize and synthesize Cs-Se NPs. Findings: The diabetic rats with Alloxan exhibited considerable serum urea, creatinine, liver enzymes, HbA1c, total cholesterol, triglycerides, and LDL increases and a significant decrease in HDL. Cs–Se NPs treatment caused the most significant dose-related changes in all the biochemical parameters with the dose of 5 mg/kg showing the most significant protective effects, which were similar or even more effective than metformin. Conclusion: Chitosanselenium nanoparticles are powerful antidiabetic agent, antioxidant agent, and organ-protective agent in alloxan-induced type 2 diabetic rats. The increased doses of Cs Se NPs proved to be more effective and thus it can be pointed out that they can serve as an effective nanotherapeutic approach in the management of diabetes and its complications.